A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer

NCT00109239 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: rhuMAb VEGF (Bevacizumab)

Sponsor

Genentech, Inc.